Calcineurin Inhibitors and Post-Transplant Hyperlipidaemias

被引:0
作者
Richard Moore
Domingo Hernandez
Hannah Valantine
机构
[1] University of Cardiff,Department of Cardiac Transplantation
[2] Renal Offices,undefined
[3] University Hospital of Wales,undefined
[4] Hospital Universitario de Canarias,undefined
[5] Stanford University Hospital,undefined
来源
Drug Safety | 2001年 / 24卷
关键词
Cyclosporin; Tacrolimus; Transplant Recipient; Everolimus; Fluvastatin;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiovascular disease is now the leading cause of death in transplant recipients. This is due, in part, to the vulnerability of these patients to a complicated set of conditions including hypertension, diabetes mellitus, and post-transplant hyperlipidaemia (PTHL). PTHL is characterised by persistent elevations in total serum cholesterol, low density lipoprotein cholesterol and triglyceride levels.
引用
收藏
页码:755 / 766
页数:11
相关论文
共 258 条
[1]  
Wheeler DC(2000)Evolution and etiology of cardiovascular diseases in renal transplant recipients Transplantation 70 SS71-5
[2]  
Steiger J(1988)Changed composition of high-density lipoprotein subclasses HDL2 and HDL3 after renal transplantation Transplantation 46 407-9
[3]  
Jung K(1998)Cardiovascular risk factors and diseases after renal transplantation Int Urol Nephrol 30 777-88
[4]  
Scheifler A(2000)Impact and management of hyperlipidemia post-transplantation Transplantation 70 SS51-7
[5]  
Blank W(1997)Post-transplant hyperlipidaemia Postgrad Med J 73 785-93
[6]  
Aker S(2000)Cardiovascular disease after renal transplantation Semin Nephrol 20 176-87
[7]  
Ivens K(1996)Hyperlipidaemia in renal transplant patients J Intern Med 239 407-15
[8]  
Grabensee B(1993)Dyslipidemia in renal transplantation: a 3-year follow-up Transplant Proc 25 2178-9
[9]  
Fellstrom B(1991)Hyperlipidemia in stable renal transplant recipients Nephron 59 423-8
[10]  
Jindal RM(1995)The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients J Am Soc Nephrol 5 2073-81